Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently completed the pre-New Drug Application (NDA) consultation with China National Medical Products Administration (NMPA) for ...
Acne is one of the most common skin conditions seen in general practice. Acne vulgaris—the most prevalent form—affects more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback